ADTX

Latest SEC Filings & News for ADTX

2 most recent filings and news items mentioning ADTX. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/ADTX/news?limit=20"

Pull ADTX filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

OfferingJun 23, 2026Neutral

Aditxt amends note purchase agreement to increase principal amount

Aditxt Inc. amended its note purchase agreement to authorize an additional $6,638,970.55 in senior secured notes. The legal agreement updates terms applicable to all buyers.

View filing at SEC.gov →

LeadershipJun 1, 2026Positive

Aditxt appoints Jeffrey M. Busch as interim CEO, replacing founder Amro Albanna

Aditxt Inc. named Jeffrey M. Busch, former CEO of NYSE-listed Global Medical REIT, as interim CEO effective May 31, 2026, while founder Amro Albanna resigned from all company positions. Busch will lead the company's commercialization strategy for its Ignite Proteomics precision o

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.